PHARMATHEN S.A. based in PALLINI-ATTIKIS, GR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-10-16

US20250319028A1

Human necessities

PHARMACEUTICAL FORMULATION COMPRISING TACROLIMUS, METHOD FOR THE PREPARATION THEREOF AND USE

#2 | 2025-08-28

US20250268830A1

Human necessities

SUSTAINED RELEASE INJECTABLE PHARMACEUTICAL FORMULATION OF LEVOTHYROXINE AND PROCESS FOR PREPARATION THEREOF

#3 | 2024-07-04

US20240216382A1

Human necessities

PEDIATRIC POWDER FOR ORAL SUSPENSION CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF

#4 | 2023-09-07

US20230277417A1

Human necessities

PROCESS AND APPARATUS FOR PREPARING VISCOUS PHARMACEUTICAL FORMULATIONS

#5 | 2023-03-09

US20230073855A1

Human necessities

SOFT GEL CAPSULE COMPRISING A SELECTIVE ESTROGEN RECEPTOR MODULATOR

#6 | 2022-12-01

US20220378698A1

Human necessities

PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING CYCLOSPORINE

#7 | 2022-10-27

US20220339159A1

Human necessities

PEDIATRIC POWDER FOR ORAL SUSPENSION CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF

#8 | 2022-06-30

US20220202720A1

Human necessities

SUSTAINED RELEASE COMPOSITION COMPRISING TAPENTADOL OXALATE AND METHOD OF PREPARATION THEREOF

#9 | 2022-06-02

US20220168241A1

Human necessities

SUSTAINED RELEASE COMPOSITION COMPRISING TAPENTADOL AND METHOD OF PREPARATION THEREOF

#10 | 2022-05-19

US20220152000A1

Human necessities

PROLONGED RELEASE FORMULATION COMPRISING TACROLIMUS

#11 | 2021-08-19

US20210253513A1

Chemistry; metallurgy

A NOVEL PROCESS FOR THE PREPARATION OF TAPENTADOL

#12 | 2021-08-05

US20210236437A1

Human necessities

SOFT GEL CAPSULE COMPRISING A SELECTIVE ESTROGEN RECEPTOR MODULATOR

#13 | 2021-06-10

US20210169807A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF

#14 | 2020-11-19 ✅ Patent 11,154,585 granted on 2021-10-26

US20200360461A1

Human necessities

Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population

#15 | 2020-09-15 ✅ Patent 10,772,830 granted on 2020-09-15

US16830883

Human necessities

Preservative free pharmaceutical compositions for ophthalmic administration

#16 | 2020-07-30

US20200237920A1

Human necessities

STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF

#17 | 2020-02-13 ✅ Patent 10,894,026 granted on 2021-01-19

US20200046670A1

Human necessities

Pharmaceutical compositions comprising a fumaric acid ester and method for the preparation thereof

#18 | 2019-10-17 ✅ Patent 11,046,810 granted on 2021-06-29

US20190315913A1

Chemistry; metallurgy

Process for preparing biodegradable polymers of high molecular weight

#19 | 2019-09-12

US20190274965A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIEMETIC AGENT AND METHOD FOR THE PREPARATION THEREOF

#20 | 2019-09-05 ✅ Patent 10,702,471 granted on 2020-07-07

US20190269612A1

Human necessities

Preservative free pharmaceutical compositions for ophthalmic administration

#21 | 2019-07-11

US20190209465A1

Human necessities

PROCESS FOR PREPARING PHARMACEUTICAL OPHTHALMIC COMPOSITIONS OF BRINZOLAMIDE

#22 | 2019-05-23

US20190151293A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A NON-PURINE SELECTIVE INHIBITOR OF XANTHINE OXIDASE AND METHOD FOR THE PREPARATION THEREOF

#23 | 2019-04-25 ✅ Patent 11,229,596 granted on 2022-01-25

US20190117562A1

Human necessities

Preservative free pharmaceutical ophthalmic compositions

#24 | 2019-04-11

US20190105277A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF

#25 | 2019-03-14

US20190076442A1

Human necessities

PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING BIMATOPROST AND TIMOLOL

#26 | 2018-08-02

US20180214381A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF

#27 | 2017-10-05 ✅ Patent 9,943,483 granted on 2018-04-17

US20170281547A1

Human necessities

Preparation of peptide loaded PLGA microspheres with controlled release characteristics

#28 | 2017-07-20

US20170202844A1

Human necessities

PEDIATRIC CHEWABLE TABLET CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF

#29 | 2017-07-20 ✅ Patent 11,969,429 granted on 2024-04-30

US20170202843A1

Human necessities

Pediatric powder for oral suspension containing antiviral agent and method for the preparation thereof

#30 | 2017-07-20 ✅ Patent 11,318,114 granted on 2022-05-03

US20170202804A1

Human necessities

Water dispersible mini-tablets comprising Enalapril for treatment of hypertension in a pediatric population and method of preparation thereof

#31 | 2017-06-15

US20170165315A1

Human necessities

ORODISPERSIBLE FILM COMPOSITION COMPRISING ENALAPRIL FOR THE TREATMENT OF HYPERTENSION IN A PEDIATRIC POPULATION

#32 | 2017-04-06 ✅ Patent 10,328,076 granted on 2019-06-25

US20170095477A1

Human necessities

Pharmaceutical composition comprising a triazole antifungal agent and method for preparation thereof

#33 | 2016-09-15 ✅ Patent 10,350,161 granted on 2019-07-16

US20160263023A1

Human necessities

Preservative free pharmaceutical compositions for ophthalmic administration

#34 | 2016-05-26 ✅ Patent 9,943,484 granted on 2018-04-17

US20160143851A1

Human necessities

Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile

#35 | 2015-10-15 ✅ Patent 9,561,186 granted on 2017-02-07

US20150290137A1

Human necessities

Method for improving the bioavailability of low aqueous solubility drugs

#36 | 2015-08-20

US20150231080A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF

#37 | 2015-07-02 ✅ Patent 9,849,147 granted on 2017-12-26

US20150182555A1

Human necessities

Pharmaceutical composition containing phosphate binding polymer

#38 | 2015-06-18

US20150165045A1

Human necessities

STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF

#39 | 2015-03-19

US20150080385A1

Human necessities

OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING A CARBONIC ANHYDRASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF

#40 | 2014-07-03

US20140187520A1

Human necessities

STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF VITAMIN D RECEPTOR AGONIST AND PROCESS FOR PREPARATION THEREOF

#41 | 2013-07-25

US20130190252A1

Human necessities

PHARMACEUTICAL FORMULATION CONTAINING LIPOPHILIC DRUGS AND MILK AS A SOLUBILIZING/DISPENSING AGENT AND METHOD FOR THE PREPARATION THEREOF

#42 | 2013-03-14 ✅ Patent 8,575,343 granted on 2013-11-05

US20130066074A1

Chemistry; metallurgy

Process for the preparation of a propenal intermediate and derivatives thereof

#43 | 2012-10-11

US20120259121A1

Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF MONTELUKAST AND SALTS THEREOF

#44 | 2012-10-04 ✅ Patent 8,754,261 granted on 2014-06-17

US20120253074A1

Chemistry; metallurgy

Process for the preparation of O-desmethyl-venlafaxine and salts thereof

#45 | 2012-10-04

US20120253051A1

Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF ROPINIROLE AND SALTS THEREOF

#46 | 2012-02-16

US20120041235A1

Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF (R)-2-(3-DIISOPROPYLAMINO)-1-PHENYLPROPYL)-4METHYLPHENOL AND SALTS THEREOF

#47 | 2012-02-09

US20120035374A1

Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF FLUVASTATIN AND SALTS THEREOF

#48 | 2011-07-14

US20110171297A1

Human necessities

SUSTAINED RELEASE FORMULATION FOR VENLAFAXINE HYDROCHLORIDE

#49 | 2011-03-17

US20110065751A1

Human necessities

Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof

#50 | 2011-02-10 ✅ Patent 8,187,635 granted on 2012-05-29

US20110033538A1

Human necessities

Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof

#51 | 2010-11-25

US20100297225A1

Human necessities

SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION CONTAINING AN ANTIMUSCARINIC AGENT AND A WETTING AGENT AS WELL AS A PROCESS FOR THE PREPARATION THEREOF

#52 | 2010-10-21 ✅ Patent 8,435,982 granted on 2013-05-07

US20100267705A1

Human necessities

Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof

#53 | 2010-08-05

US20100196469A1

Human necessities

Pharmaceutical Formulation containing an HMG-COA Reductase Inhibitor and method for the preparation thereof

#54 | 2010-06-03 ✅ Patent 8,835,486 granted on 2014-09-16

US20100137400A1

Human necessities

Pharmaceutical formulation containing an HMG-COA reductase inhibitor and method for the preparation thereof

#55 | 2010-04-15

US20100094055A1

Chemistry; metallurgy

PROCESS FOR THE PREPARATION OF PHENETHYLAMINE DERIVATIVES

#56 | 2008-09-04

US20080213356A1

Human necessities

Pharmaceutical Composition Containing Hmg-Coa Reductase Inhibitor And Method For The Preparation Thereof

Also check out PHARMATHEN S.A.'s (Pallini Attikis, Greece) applicant profile with 13 patent applications submitted.

AssigneeID:

13962 ⎘